Target- |
MechanismStem cell replacements |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhaseIND Application |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Chuangzhixing (Guangzhou) Biotechnology Co., Ltd.
0 Patents (Medical) associated with Chuangzhixing (Guangzhou) Biotechnology Co., Ltd.
100 Deals associated with Chuangzhixing (Guangzhou) Biotechnology Co., Ltd.
100 Translational Medicine associated with Chuangzhixing (Guangzhou) Biotechnology Co., Ltd.